Gene sequencing is a popular track that has attracted a lot of attention recently, but most stock investors don’t know what the gene sequencing concept stocks are. Today, Financial Manager has sorted out the real leading stocks in the gene sequencing concept sector for stock investors. A list is provided for your reference.
New Kaiyuan (300109)
The main business of Boai New Kaiyuan (300109) Medical Technology Group Co., Ltd. includes fine chemicals and precision medicine. The main products of the fine chemical business include: polyvinylpyrrolidone (PVP) series and related intermediates, vinyl methyl ether/maleic anhydride polymer (PVM/MA, Orizzi) and related intermediates, and oral care related series wait. The main products/services of the precision medicine business include: early tumor screening with gene sequencing as the main technology platform, molecular diagnosis of women's diseases, personalized medical services, etc. In September 2009, the company was recognized as a "high-tech enterprise", with certificate number: GR200941000051, valid for 3 years.
Airport Technology Park Co., Ltd. (600463)(600463)
Beijing Airport Science and Technology Park Co., Ltd. is the only airport-type park listed company in China. The company is based in the airport economic core area of ??Beijing. With park development and construction as its main business, it has formed a park development and construction industry chain including primary land development, industrial real estate development, building engineering construction, property leasing and management business.
CCT Testing (300012)
CCT Testing (300012) Certification Group Co., Ltd. is a comprehensive third party integrating testing, calibration, inspection, certification and technical services. agency, providing one-stop solutions globally. The company's main services are food agriculture and health product services, environmental testing services, medical health services, construction engineering and industrial services, measurement and digital services, consumer goods services, automotive industry chain services, and electronic technology services. The company is one of the earliest and most invested professional research institutions in domestic private testing institutions. It has also established a group research institute. Relying on the technical support of the research institute, it continuously improves the company's core competitiveness in the field of testing technology and conducts research and development with industry experts as the core. The team concentrates on researching cutting-edge technologies in the industry, providing strong technical support for the business expansion of major business divisions, and obtaining sufficient technical preparations.
Novogene (688315)
Beijing Novogene Technology Co., Ltd.’s main business is to provide multi-level scientific research technology in basic research in life sciences, medicine and clinical application research. Services and solutions, while independently developing innovative genetic testing medical devices. The main products include basic scientific research services in life sciences, medical research and technical services, and library construction and sequencing platform services.
***jin Electronics Co., Ltd. (603118)
Shenzhen ***jin Electronics Co., Ltd. is mainly engaged in the research and development of broadband communication terminal equipment, mobile communications and communication application equipment, etc. Production and sales. The main products include broadband communication terminal equipment, mobile communication and communication application equipment. As a large domestic manufacturer of broadband communication terminals, the company mainly provides manufacturing services for network communication products for domestic and foreign communication equipment providers such as ZTE, Shanghai Bell, FiberHome Communications (600498), D-Link, SAGEM, etc. through ODM mode, and Obtained a direct order from British Telecom, a telecommunications operator.
Hanwang Technology (002362)(002362)
Hanwang Technology Co., Ltd. is engaged in computer vision (text image recognition, biometric recognition, video structuring), natural language processing, intelligence Research on human-computer interaction technology. The main products or businesses are pen intelligent interaction, text big data and services, AI terminals, face and biometric recognition, etc. The company has repeatedly won honors such as the National Science and Technology Progress Award and the Beijing Science and Technology Award; the company's research and development has been recognized by technology centers such as the "National Enterprise Technology Center" and the "Beijing Paperless Office Information Collection Equipment Engineering Technology Research Center". Currently, the company has 796 valid patents, including 487 invention patents, 174 utility models, and 135 designs. It also has 711 registered trademarks and 299 software copyrights.
Ronglian Technology (002642)
The main business of Ronglian Technology Group Co., Ltd. is divided into three major sectors, including enterprise services, Internet of Things and big data, and life sciences.
It mainly includes system integration services, T operation and maintenance services, technical development and services, biological information analysis platform, analysis software, all-in-one machines and cloud services. During the reporting period, the company also received recognition and affirmation from multiple government departments, media organizations and industry associations in the field of professional technical services. Among them, Rongrui Cloud Data Analysis Platform was listed in the "Top 100 Excellent Cases of Digital Application in the Digital Ecological Industry in 2021" and won the "Excellent Digital Case Award in the Digital Ecological Industry in 2021"; Rongrui Metal Mine's digital twin multi-dimensional integrated collaborative management and control solution won the "The best solution for China's big data energy mining industry in 2021"; multiple products were selected into the 2021 big data industry ecological map, the 2021 big data industry development white paper, and the top 100 cases of digital transformation ecological construction in 2021; brand influence...
Zixin Pharmaceutical (002118)
The main businesses of Jilin Zixin Pharmaceutical (002118) Co., Ltd. are Chinese patent medicine industry, ginseng industry, and industrial hemp industry. The company's main products include pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, lozenges, ginseng products, and industrial hemp products. The company's "Zixin" trademark is a well-known trademark in China and a famous trademark in Jilin Province. The company has been rated as "Quality-oriented Unit in China's Pharmaceutical Industry" and "The Most Reputation Unit in Jilin Province"; "Fake-Free Unit in China's Pharmaceutical (600056) Industry"; and "AAA-Level Chinese Integrity Enterprise".
Aide Biotechnology (300685)
The main business of Xiamen Aide Biomedical Technology Co., Ltd. is the research and development, production and sales of tumor precision medical molecular diagnostic products, and provides related Testing services. The company's products mainly include molecular diagnostic reagents for targeted tumor precision medicine and molecular diagnostic reagents for tumor chemotherapy drugs, which are used to detect the genetic status of tumor patients and provide molecular diagnostic reference for clinicians to formulate precision medical treatment plans. The company has the qualifications of "National High-tech Enterprise" and "National Intellectual Property Advantage Enterprise", and is part of the "Twelfth Five-Year Plan" 863 Plan. The company has 21 Class III medical device registration certificates; the company has obtained 38 patent authorizations, and its core invention patents have been authorized by China, the United States, the European Union, and Japan, and won the second prize of the National Science and Technology Progress Award and the National Patent Silver Award.
Guofa Co., Ltd. (600538)
Beihai Guofa Chuanshan Biological Co., Ltd. (600201) Co., Ltd.’s main businesses are pharmaceutical manufacturing and pharmaceutical distribution business, molecular medical imaging center and tumor radiotherapy Center and tumor telemedicine technical services, in vitro diagnosis and forensic identification business. The company's main products are wholesale business, chain retail, Pearl Eye Drops and ethanol disinfectant. Pearl Bright Eye Eye Drops has been included in the national medical insurance catalog. The market and consumers have responded well and it has certain competitiveness.